Your Shopping Cart Is Empty
| Report Code: A04898 | Nov 2021 | Pages: 189 | ||
| Tables: 87 | Charts: 33 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Fetal Bovine Serum Market
Request Now !The global fetal bovine serum market size was valued at $796.25 million in 2020, and is projected to reach $1,375.53 million by 2030, registering a CAGR of 5.4% from 2021 to 2030. Fetal Bovine serum is a nutrient-rich fluid derived from the blood of bovine fetuses. Fetal bovine serum (FBS) is a major component of animal cell culture media, which is obtained from bovine fetuses of cows. It has several nutritional and macromolecular factors that are essential for cell growth. Besides this, it also comprises amino acids, sugars, lipids, hormones, and low gamma globulin content. As a result, it is widely utilized in a range of applications, such as providing essential nutrients and facilitating cell survival and proliferation in eukaryotic cell culture. It is also used in research, manufacturing, biotech drugs, and controlling human and veterinary vaccines.
The fetal bovine serum market is expected to be positively impacted by the COVID-19 pandemic. As fetal bovine serum has extensively been used in vaccine production and in-vitro cell-culture preparation in healthcare industries. This factor has impacted the global fetal bovine serum market positively during the pandemic.
FBS is used in a wide range of applications. One of the primary uses of FBS is in eukaryotic cell culture, with concentration, where it provides many essential nutrients and growth factors that facilitate cell survival and proliferation.
The global fetal bovine serum market is driven by factors such as rapid increase in culture media consumption in developing countries across the world is key factor driving the growth and demand of fetal bovine serum market. Furthermore, rise in R&D activities toward the introduction of novel biopharmaceuticals and expansion of the biopharmaceutical industry is anticipated to drive the growth of market. Moreover, an increase in investments and funding for research interventions in both developed and developing countries drives market growth.
However, ethical & scientific concerns associated with the potential misuse of biotechnology research practices and dearth of skilled personnel restrict the fetal bovine serum market. In addition, ease of availability of alternatives such as chemically defined media, serum-free media, and others hampers the market growth. In addition, the fetal bovine serum market is experiencing paradigm shift, due to significant rise in prices of FBS over the recent years, which acts as a key restraint. This increase in price is attributed to the significant surge in demand for FBS while decrease in its production. On the contrary, untapped potential of emerging markets are anticipated to provide lucrative opportunities in the near future to the key players operating in the fetal bovine serum market.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Due to the COVID-19 pandemic, governments across the globe announced country-wide lockdowns as well as social distancing measures to prevent collapse of the healthcare system. Governments have also issued limitations and bans on medical procedures and elective surgeries. These restrictions continue to impact the growth of various industries, and the immediate impact of the outbreak varies from industry to industry.
The distribution, production, and supply chain have been affected, due to the implementation of lockdown across the globe.
The overall impact of COVID-19 remains positive for fetal bovine serum market. As fetal bovine serum is used extensively in in-vitro cell-culture preparation and vaccine production. The in vitro evaluation of vaccine and antivirals generally requires a culture media in which the targeted virus or bacteria is cultured and the response is identified. Fetal bovine serum is used as a supplement in the growth media for vaccines.
For instance, according to a research article titled 'Role of Viral Transport Media in Sustaining COVID-19 Testing' published in October 2020, Viral Transport Media is generally composed of Fetal Bovine Serum (FBS). A viral transport media is used for preserving and transporting samples. A viral transport media (VTM) is preferred over other types, as it is a non-toxic mixture of antimicrobials and buffered solutions that can preserve the COVID-19 virus while eliminating contaminant flora that might interfere with testing. Fetal bovine serum-based VTM has proven compatibility with a wide range of clinical tests from PCR to direct antigen testing to culture, allowing different tests to be run from the same sample. Thus, the fetal bovine serum market is expected to experience rapid growth.
The global fetal bovine serum market is classified on the basis of application, end user and region. By application, it is segmented into biopharmaceuticals, human & animal vaccines and others. By end user, the market is categorized biotechnology & pharmaceutical industries, academic institutes & others. By region, the market is analyzed across, North America, Europe, Asia-Pacific and LAMEA.
By application, the pharmaceuticals segment was the major revenue contributor, and is projected to grow significantly, owing to increase in adoption biopharmaceuticals drugs and increase in the prevalence of chronic disease such as cancer, arthritis and cardiovascular disease across the world are the key factors anticipating the growth of market.
By end user, the biotechnology & pharmaceutical industries segment was the major revenue contributor, and is projected to grow significantly during the forecast period, owing to increased use of FBS for biopharmaceuticals and human & animal vaccine production. In addition, increase in demand from users of traditional serum and advancements in research and academic initiatives by private and government sectors are the major factors contributing toward the market growth.
By region, North America accounted for the largest share in 2020, and is anticipated to maintain its dominance from 2020 to 2030, owing to increase in R&D activities to develop antibody base therapy for various disease, presence of major players & their product availability, and well-established healthcare infrastructure in the region.
The key market players profiled in the fetal bovine serum market include Danaher (Cytiva), Merck KGaA (Sigma Aldrich), HiMedia Laboratories Pvt., Ltd, Bio-Techne, Sera Scandia (Biowest), Sartorius (Biological Industries), Atlas Biologicals, Rocky Mountain Biologicals, PAN-Biotech and Thermo Fisher Scientific Inc.
Key Benefits For Stakeholders
Fetal Bovine Serum Market Report Highlights
| Aspects | Details |
|---|---|
| By application |
|
| By End User |
|
| By Region |
|
| By Key Market Players |
|
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.3.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key Forces Shaping Fetal Bovine Serum Industries/Market
3.2.1.Moderate bargaining power of suppliers
3.2.2.Low bargaining power of buyers
3.2.3.Low threat of substitutes
3.2.4.Low intensity of rivalry
3.2.5.Moderate Threat of Substitution
3.4.Market evolution/Industries roadmap
3.5.Value Chain Analysis
3.6.Impact of government regulations on global fetal bovine serum market
3.7.Industries Pain point analysis
3.8.Key findings
3.8.1.Top impacting factors
3.8.2.Top investment pockets
3.8.3.TOP PLAYER POSITIONING, 2020
3.9.Case Studies
3.9.1.Case Study 01
3.10.Market dynamics
3.10.1.Drivers
3.10.1.1.Rise in R&D investments
3.10.1.2.High demand for fetal bovine sera
3.10.1.3.Surge in biopharmaceutical production
3.10.2.Restraints
3.10.2.1.Ethical and scientific issues associated with collection of fetal bovine serum
3.10.2.2.Increase in use of alternatives
3.10.3.Opportunity
3.10.3.1.Untapped potential of emerging economies
3.10.4.COVID-19 Impact analysis
CHAPTER 4:FETAL BOVINE SERUM MARKET, BY APPLICATION
4.1.Overview
4.1.1.Market size and forecast, by application
4.2.Biopharmaceuticals
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Human & Animal Vaccine
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:FETAL BOVINE SERUM MARKET, BY END USER
5.1.Overview
5.1.1.Market size and forecast, by end user
5.2.Biotechnology & Pharmaceutical Industries
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Academic Institutes
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:FETAL BOVINE SERUM MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by end user
6.2.5.1.U.S.
6.2.5.2.U.S. Market size and forecast, by application
6.2.5.3.Market size and forecast, by end user
6.2.5.4.Canada
6.2.5.5.Canada Market size and forecast, by application
6.2.5.6.Canada Market size and forecast, by end user
6.2.5.7.Mexico
6.2.5.8.Mexico Market size and forecast, by application
6.2.5.9.Mexico Market size and forecast, by end user
6.3.Europe
6.3.1.Key market trends, growth factors and opportunities
6.3.2.Europe Market size and forecast, by country
6.3.3.Market size and forecast, by application
6.3.4.Europe Market size and forecast, by end user
6.3.4.1.Germany
6.3.4.2.Germany Market size and forecast, by application
6.3.4.3.Germany Market size and forecast, by end user
6.3.4.4.France
6.3.4.5.France Market size and forecast, by application
6.3.4.6.France Market size and forecast, by end user
6.3.4.7.UK
6.3.4.8.UK Market size and forecast, by application
6.3.4.9.UK Market size and forecast, by end user
6.3.4.10.Italy
6.3.4.11.Italy Market size and forecast, by application
6.3.4.12.Market size and forecast, by end user
6.3.4.13.Spain
6.3.4.14.Spain Market size and forecast, by application
6.3.4.15.Spain Market size and forecast, by end user
6.3.4.16.Rest of Europe
6.3.4.17.Rest of Europe Market size and forecast, by application
6.3.4.18.Rest of Europe Market size and forecast, by end user
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by country
Market size and forecast, by application
6.4.3.Market size and forecast, by end user
6.4.3.1.Japan
6.4.3.2.Japan Market size and forecast, by application
6.4.3.3.Japan Market size and forecast, by end user
6.4.3.4.China
6.4.3.5.China Market size and forecast, by application
6.4.3.6.China Market size and forecast, by end user
6.4.3.7.Australia
6.4.3.8.Australia Market size and forecast, by application
6.4.3.9.Australia Market size and forecast, by end user
6.4.3.10.India
6.4.3.11.India Market size and forecast, by application
6.4.3.12.India Market size and forecast, by end user
6.4.3.13.South Korea
6.4.3.14.South Korea Market size and forecast, by application
6.4.3.15.South Korea Market size and forecast, by end user
6.4.3.16.Rest of Asia-Pacific
6.4.3.17.Rest of Asia-Pacific Market size and forecast, by application
6.4.3.18.Rest of Asia-Pacific Market size and forecast, by end user
6.5.LAMEA
6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by country
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by end user
6.5.4.1.Brazil
6.5.4.2.Brazil Market size and forecast, by application
6.5.4.3.Brazil Market size and forecast, by end user
6.5.4.4.Saudi Arabia
6.5.4.5.Saudi Arabia Market size and forecast, by application
6.5.4.6.Saudi Arabia Market size and forecast, by end user
6.5.4.7.South Africa
6.5.4.8.South Africa Market size and forecast, by application
6.5.4.9.South Africa Market size and forecast, by end user
6.5.4.10.Rest of LAMEA
6.5.4.11.Rest of LAMEA Market size and forecast, by application
6.5.4.12.Rest of LAMEA Market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES:
7.1.ATLAS BIOLOGICALS
7.1.1.Company overview
7.1.2.Company snapshot
7.2.BIO-TECHNE (ATLANTA BIOLOGICS)
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.Danaher (cytiva)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.HIMEDIA LABORATORIES PVT., LTD
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.5.Merck KGAA (SIGMA ALDRICH)
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.PAN-BIOTECH
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.7.ROCKY MOUNTAIN BIOLOGICALS (RMBIO)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.8.SARTORIUS (Biological industries)
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.SERA SCANDIA A/S (BIOWEST)
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.10.THERMO FISHER SCIENTIFIC INC.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product Portfolio
7.10.5.Business performance
7.11.Other Key Player Profile
7.11.1.Key player snapshot
LIST OF TABLES
TABLE 01.FETAL BOVINE SERUM MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 02.FETAL BOVINE SERUM MARKET FOR BIOPHARMACEUTICALS, BY REGION 2020–2030($MILLION)
TABLE 03.FETAL BOVINE SERUM MARKET FOR HUMAN AND ANIMAL VACCINE PRODUCTION, BY REGION 2020–2030 ($MILLION)
TABLE 04.FETAL BOVINE SERUM MARKET FOR OTHERS, BY REGION 2020–2030 ($MILLION)
TABLE 05.GLOBAL FETAL BOVINE SERUM MARKET, BY END USER 2020–2030 ($MILLION)
TABLE 06.FETAL BOVINE SERUM MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES, BY REGION 2020–2030 ($MILLION)
TABLE 07.FETAL BOVINE SERUM MARKET REVENUE FOR ACADEMIC INSTITUTES, BY REGION 2020–2030 ($MILLION)
TABLE 08.FETAL BOVINE SERUM MARKET REVENUE FOR OTHERS, BY REGION 2020–2030($MILLION)
TABLE 09.GLOBAL FETAL BOVINE SERUM MARKET, BY REGION 2020–2030 ($MILLION)
TABLE 10.NORTH AMERICA FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2020–2030 ($MILLION)
TABLE 11.NORTH AMERICA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 12.NORTH AMERICA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 13.U.S. FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 14.U.S. FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 15.CANADA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 16.CANADA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 17.MEXICO FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 18.MEXICO FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 19.EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2020–2030 ($MILLION)
TABLE 20.EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 21.EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 22.GERMANY FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 23.GERMANY FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 24.FRANCE FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 25.FRANCE FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 26.UK FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 27.UK FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 28.ITALY FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 29.ITALY FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 30.SPAIN FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 31.SPAIN FETAL BOVINE SERUM MARKET REVENUE, BY END USER 202-2030($MILLION)
TABLE 32.REST OF EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030($MILLION)
TABLE 33.REST OF EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030($MILLION)
TABLE 34.ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2020–2030 ($MILLION)
TABLE 35.ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030($MILLION)
TABLE 36.ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 37.JAPAN FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 38.JAPAN FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 39.CHINA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 40.CHINA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 41.AUSTRALIA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 42.AUSTRALIA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 43.INDIA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 44.INDIA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 45.SOUTH KOREA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 46.SOUTH KOREA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 47.REST OF ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 49.LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2020–2030 ($MILLION)
TABLE 50.LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 51.LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 52.BRAZIL FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 53.BRAZIL FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 54.SAUDI ARABIA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 55.SAUDI ARABIA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 56.SOUTH AFRICA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 57.SOUTH AFRICA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 58.REST OF LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2020–2030 ($MILLION)
TABLE 59.REST OF LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2020–2030 ($MILLION)
TABLE 60.ATLAS: COMPANY SNAPSHOT
TABLE 61.BIO-TECHNE COMPANY SNAPSHOT
TABLE 62.BIO-TECHNE OPERATING SEGMENTS
TABLE 63.BIO-TECHNE: PRODUCT PORTFOLIO
TABLE 64.DANAHER: COMPANY SNAPSHOT
TABLE 65.DANAHER: OPERATING SEGMENTS
TABLE 66.DANAHER HEALTHCARE: PRODUCT PORTFOLIO
TABLE 67.HIMEDIA: COMPANY SNAPSHOT
TABLE 68.HIMEDIA: OPERATING SEGMENTS
TABLE 69.HI MEDIA: PRODUCT PORTFOLIO
TABLE 70.MERCK: COMPANY SNAPSHOT
TABLE 71.MERCK: OPERATING SEGMENTS
TABLE 72.MERCK: PRODUCT PORTFOLIO
TABLE 73.PAN: COMPANY SNAPSHOT
TABLE 74.PAN: OPERATING SEGMENTS
TABLE 75.PAN: PRODUCT PORTFOLIO
TABLE 76.RMBIO: COMPANY SNAPSHOT
TABLE 77.RMBIO: OPERATING SEGMENTS
TABLE 78.RMBIO: PRODUCT PORTFOLIO
TABLE 79.SARTORIUS: COMPANY SNAPSHOT
TABLE 80.SARTORIUS: OPERATING SEGMENTS
TABLE 81.SARTORIUS: PRODUCT PORTFOLIO
TABLE 82.SERA SCANDIA: COMPANY SNAPSHOT
TABLE 83.BIOWEST: OPERATING SEGMENTS
TABLE 84.SERA SCANDIA: PRODUCT PORTFOLIO
TABLE 85.THERMO FISHER: COMPANY SNAPSHOT
TABLE 86.THERMO FISHER: OPERATING SEGMENTS
TABLE 87.THERMO FISHER: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.MARKET EVOLUTION/INDUSTRIES ROADMAP
FIGURE 03.VALUE CHAIN ANALYSIS
FIGURE 04.TOP IMPACTING FACTORS
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.MARKET PLAYER POSITIONING, 2020
FIGURE 07.FETAL BLOOD COLLECTION PROCESS
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR BIOPHARMACEUTICALS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR HUMAN AND ANIMAL VACCINE PRODUCTION, BY COUNTRY, 2020 & 2030 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR OTHER, BY COUNTRY, 2020 & 2030 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES, BY COUNTRY, 2020 & 2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR ACADEMIC INSTITUTESS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15.BIO-TECHNE NET SALES, 2018–2020 ($MILLION)
FIGURE 17.BIO-TECHNE REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 18.BIO-TECHNE REVENUE SHARE, BY REGION 2020 (%)
FIGURE 19.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 21.DANAHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 22.MERCK: REVENUE, 2018–2020 ($MILLION)
FIGURE 24.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 28.SARORIUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.SARTORIOUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.SARTORIUS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.THERMO FISHER: REVENUE SHARE BY REGION, 2020 (%)
Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves. It contains a high amount of nutritional and macromolecular factors essential for cell growth. FBS also contains a variety of small molecules like amino acids, sugars, lipids, and hormones.
Factors such as rise in R&D activities toward the introduction of novel biopharmaceuticals and increase in investments and funding for research interventions in both developed and developing countries drives the market growth. In addition, significant rise in the use of sera for cell culture and low supply of the same is anticipated to increase the cost in near future. Furthermore, the rising usage of FBS in primary cell cultures for in-vitro testing and drug screening are the key factors anticipating growth of market. However, scientific and ethical concerns associated with biotechnology and dearth of skilled professionals hamper the growth of the market.
A. The total market value ofFetal Bovine Serum Market is $1,375.53 Million in 2030
A. The forecast period in the report is from 2021 to 2030
A. The market value of Fetal Bovine Serum in 2020 was 796.25 million in 2020
A. The base year for the report is 2020
A. Yes, Fetal Bovine Serum Market companies are profiled in the report
A. The top companies that hold the market share in Fetal Bovine Serum Market are Danaher (Cytiva), Merck KGaA (Sigma Aldrich), HiMedia Laboratories Pvt., Ltd, Bio-Techne, Sera Scandia (Biowest), Sartorius (Biological Industries)
A. No, there is no value chain analysis provided in the Fetal Bovine Serum Market report
A. The key trends in the Fetal Bovine Serum Market are rise in R&D activities toward the introduction of novel biopharmaceuticals and expansion of the biopharmaceutical industry is anticipated to drive the growth of market
Start reading instantly.
This Report and over 66,782+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report